88 related articles for article (PubMed ID: 9520155)
1. Modulation of P-glycoprotein-mediated multidrug resistance in a doxorubicin-resistant subline of the human lymphoblastoid cell line CCRF-CEM by phosphorothioate antisense oligonucleotides.
Dassow H; Lassner D; Remke H; Preiss R
Int J Clin Pharmacol Ther; 1998 Feb; 36(2):93-6. PubMed ID: 9520155
[No Abstract] [Full Text] [Related]
2. Reversal of multiple drug resistance in vitro by phosphorothioate oligonucleotides and ribozymes.
Bertram J; Palfner K; Killian M; Brysch W; Schlingensiepen KH; Hiddemann W; Kneba M
Anticancer Drugs; 1995 Feb; 6(1):124-34. PubMed ID: 7756675
[TBL] [Abstract][Full Text] [Related]
3. Co-transfection of MDR1 and MRP antisense RNAs abolishes the drug resistance in multidrug-resistant human lung cancer cells.
Gao Z; Gao Z; Fields JZ; Boman BM
Anticancer Res; 1998; 18(4C):3073-6. PubMed ID: 9713512
[TBL] [Abstract][Full Text] [Related]
4. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
Ramachandran C; Wellham LL
Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
[TBL] [Abstract][Full Text] [Related]
5. Cytofluorimetric analysis of a renal tubular cell line and its resistant counterpart.
Rosati A; Decorti G; Klugmann FB; Candussio L; Granzotto M; Melato M; Giraldi T
Anticancer Res; 2000; 20(5B):3403-10. PubMed ID: 11131640
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas.
Hinoshita E; Uchiumi T; Taguchi K; Kinukawa N; Tsuneyoshi M; Maehara Y; Sugimachi K; Kuwano M
Clin Cancer Res; 2000 Jun; 6(6):2401-7. PubMed ID: 10873092
[TBL] [Abstract][Full Text] [Related]
7. Anticancer drug sensitivity and expression of multidrug resistance markers in early passage human sarcomas.
Hoffmann J; Schmidt-Peter P; Hänsch W; Naundorf H; Bunge A; Becker M; Fichtner I
Clin Cancer Res; 1999 Aug; 5(8):2198-204. PubMed ID: 10473106
[TBL] [Abstract][Full Text] [Related]
8. Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells.
Meschini S; Calcabrini A; Monti E; Del Bufalo D; Stringaro A; Dolfini E; Arancia G
Int J Cancer; 2000 Sep; 87(5):615-28. PubMed ID: 10925353
[TBL] [Abstract][Full Text] [Related]
9. Multidrug resistance-1 and p-glycoprotein in human chondrosarcoma cell lines: expression correlates with decreased intracellular doxorubicin and in vitro chemoresistance.
Wyman JJ; Hornstein AM; Meitner PA; Mak S; Verdier P; Block JA; Pan J; Terek RM
J Orthop Res; 1999 Nov; 17(6):935-40. PubMed ID: 10632461
[TBL] [Abstract][Full Text] [Related]
10. Reduction of expression of the multidrug resistance protein (MRP) in human tumor cells by antisense phosphorothioate oligonucleotides.
Stewart AJ; Canitrot Y; Baracchini E; Dean NM; Deeley RG; Cole SP
Biochem Pharmacol; 1996 Feb; 51(4):461-9. PubMed ID: 8619891
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cytotoxicity and nuclear accumulation of doxorubicin-loaded nanospheres in human breast cancer MCF7 cells expressing MRP1.
Aouali N; Morjani H; Trussardi A; Soma E; Giroux B; Manfait M
Int J Oncol; 2003 Oct; 23(4):1195-201. PubMed ID: 12964004
[TBL] [Abstract][Full Text] [Related]
13. Reversal of drug sensitivity in MDR subline of P388 leukemia by gene-targeted antisense oligonucleotide.
Nakashima E; Matsushita R; Negishi H; Nomura M; Harada S; Yamamoto H; Miyamoto K; Ichimura F
J Pharm Sci; 1995 Oct; 84(10):1205-9. PubMed ID: 8801335
[TBL] [Abstract][Full Text] [Related]
14. Modulation of multidrug resistance in a cancer cell line by anti-multidrug resistance-associated protein (MRP) ribozyme.
Hatanaka H; Abe Y; Naruke M; Asai S; Miyachi H; Kawakami T; Nagata J; Kamochi J; Kijima H; Yamazaki H; Scanlon KJ; Ueyama Y; Nakamura M
Anticancer Res; 2001; 21(2A):879-85. PubMed ID: 11396179
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of resistance associated genes in hepatoblastoma xenografts incorporated into mice following treatment with adriamycin or cisplatin.
Bader P; Fuchs J; Wenderoth M; von Schweinitz D; Niethammer D; Beck JF
Anticancer Res; 1998; 18(4C):3127-32. PubMed ID: 9713521
[TBL] [Abstract][Full Text] [Related]
16. The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance.
Li G; Chen X; Wang Q; Xu Z; Zhang W; Ye L
J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):173-5. PubMed ID: 17497289
[TBL] [Abstract][Full Text] [Related]
17. Resistance to the new anti-cancer phospholipid ilmofosine (BM 41 440).
Hofmann J; Utz I; Spitaler M; Hofer S; Rybczynska M; Beck WT; Herrmann DB; Grunicke H
Br J Cancer; 1997; 76(7):862-9. PubMed ID: 9328144
[TBL] [Abstract][Full Text] [Related]
18. Effects of 1,2-naphthoquinones on human tumor cell growth and lack of cross-resistance with other anticancer agents.
Dolan ME; Frydman B; Thompson CB; Diamond AM; Garbiras BJ; Safa AR; Beck WT; Marton LJ
Anticancer Drugs; 1998 Jun; 9(5):437-48. PubMed ID: 9660542
[TBL] [Abstract][Full Text] [Related]
19. The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance.
Gekeler V; Ise W; Sanders KH; Ulrich WR; Beck J
Biochem Biophys Res Commun; 1995 Mar; 208(1):345-52. PubMed ID: 7887949
[TBL] [Abstract][Full Text] [Related]
20. Increase of P-glycoprotein-mediated drug resistance by hsp 90 beta.
Bertram J; Palfner K; Hiddemann W; Kneba M
Anticancer Drugs; 1996 Nov; 7(8):838-45. PubMed ID: 8991187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]